Treatment of Low-Risk Superficial or Nodular Basal Cell Carcinoma
This protocol covers the management of basal cell carcinoma of the skin in the low-risk setting — specifically superficial BCC and low-risk nodular BCC — where treatment selection and the definition of success are clearly established.
Clinical Scenario
Superficial basal cell carcinoma (low-risk), or low-risk nodular basal cell carcinoma. This group encompasses patients in whom topical therapies and destructive approaches may also be considered as part of a broader management discussion.
Treatment Goal
Histologically tumour-free surgical margins — confirming complete excision. When clear margins are confirmed, no further excision is required.
Treatment Approach (partial overview)
The standard of care involves surgical excision with histopathological confirmation of margins. The full protocol specifies the required technique, margin parameters, and histological assessment method — see the complete regimen below.
References
DOI: 10.1016/j.ejca.2023.113254
Surgical excision followed by histopathological confirmation shall be offered as standard of care to treat BCC.
In low-risk BCCs, a safety margin of 3–4 mm is recommended for standard excision with 2D histology.
Topical therapies and destructive approaches can be considered in patients with low-risk superficial BCC.
Photodynamic therapy is an effective treatment for superficial and low-risk nodular BCCs.
If histologically-free margins are reported, re-excision is not required.
View source ↗